RLMD Relmada Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$3,60
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,8052 haftanın en düşüğü
$8,0052 haftanın en yükseği
Piyasa Değeri (MRQ)
$384M
P/E
-2.5
Hisse Başına Kâr
$-1.45
rozetleriniz
52 Haftlık Aralık
$2–$8
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$11
P/E
-2.5
ROE
-112.0%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
RLMD Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$3.60
Piyasa Değeri (MRQ)
$384M
P/E
-2.5
Hisse Başına Kâr
$-1.45
ROE
-112.0%
52 Haftlık Aralık
$2–$8
RLMD Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 30 Eylül 2019 | 1-for-4 | Ters |
| 12 Ağustos 2015 | 1-for-5 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-1.452021-12-31 → 2025-12-31
Serbest Nakit Akışı·2018-06-30 → 2020-12-31
Net kar marjı·2018-06-30 → 2023-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | RLMD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -2.55Y ort. ≈-1.7 | ≈-1.7 | · | · | |
| P/S (F/S) | 47895.75Y ort. ≈44431.6 | ≈44431.6 | 55.0 | Aşırı değerli | |
| F/D (MRQ) | 1.95Y ort. ≈1.9 | ≈1.9 | 3.0 | Aşırı değerli | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -5.85Y ort. ≈-3.7 | ≈-3.7 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 3.15Y ort. ≈1.9 | ≈1.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | RLMD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -82.1%5Y ort. ≈-85.9% | ≈-85.9% | -24.7% | Zayıf | |
| ROE | -112.0%5Y ort. ≈-120.5% | ≈-120.5% | -28.4% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | RLMD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 29.55Y ort. ≈10.8 | ≈10.8 | 8.1 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 14.55Y ort. ≈10.0 | ≈10.0 | 7.5 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | RLMD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 93.7%5Y ort. ≈67.1% | ≈67.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 54.4% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-44.2%
Sonraki Rapor
Kas 11, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 11, 2026 | $-0.11 | $-0.20 | 45.9% |
| 31 Mart 2026 | May 12, 2026 | $-0.22 | $-0.20 | -10.6% |
| 31 Aralık 2025 | $-0.29 | $-0.14 | -103.1% | |
| 30 Eylül 2025 | $-0.30 | $-0.12 | -153.6% | |
| 30 Haziran 2025 | $-0.30 | $-0.26 | -17.6% | |
| 31 Mart 2025 | $-0.58 | $-0.32 | -83.4% | |
| 31 Aralık 2024 | $-0.62 | $-0.71 | 13.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $27M | $46M | $55M | $113M | $91M | $36M | $8M | $3M | $1M | · | · | |
| SG&A Expense | $32M | $38M | $49M | $48M | $35M | $25M | $7M | $4M | $6M | · | · | |
| Operating Expenses | $59M | $84M | $104M | $161M | $126M | $61M | $15M | $7M | $7M | · | · | |
| Operating Income | $-59M | $-84M | $-104M | $-161M | $-126M | $-61M | $-15M | $-7M | $-7M | · | · | |
| Interest Income | $1M | $4M | $5M | · | · | · | · | · | · | · | · | |
| Other Non-op | $2M | $4M | $5M | $4M | $-48.3K | $1M | $104.1K | $-2M | $932.3K | · | · | |
| Net Income | $-57M | $-80M | $-99M | $-157M | $-126M | $-59M | $-15M | $-9M | $-6M | · | · | |
| EPS (Basic) | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 | · | · | · | · | · | · | |
| Shares (Basic) | 39,479,694 | 30,163,751 | 30,099,203 | 29,628,664 | 17,552,738 | · | · | · | · | · | · | |
| Shares (Diluted) | 39,479,694 | 30,163,751 | 30,099,203 | 29,628,664 | 17,552,738 | · | · | · | · | · | · | |
| EBITDA | $-59M | $-84M | $-104M | $-161M | $-126M | $-61M | · | $-7M | · | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $4M | $4M | $5M | $44M | $2M | $36M | $2M | $2M | $9M | · | |
| Short-term Investments | $90M | $41M | $92M | $143M | $167M | $115M | $80M | · | · | · | · | |
| Receivables | · | · | · | $512.4K | · | · | · | · | · | · | · | |
| Prepaid Expense | $977.7K | $886.5K | $1M | $4M | $11M | $903.2K | $423.9K | $426.9K | $472.5K | · | · | |
| Current Assets | $94M | $46M | $98M | $153M | $223M | $118M | $117M | $3M | $2M | · | · | |
| PP&E (Net) | · | · | · | · | · | $1.3K | $5.0K | $12.1K | $2.3K | · | · | |
| PP&E (Gross) | · | · | · | · | $16.7K | $16.7K | $16.7K | $16.7K | $4.3K | · | · | |
| Accum. Depreciation | · | · | · | · | $16.7K | $15.4K | $11.7K | $4.6K | $2.0K | · | · | |
| Other Non-current Assets | $19.5K | $22.0K | $43.1K | $34.9K | $28.3K | $25.0K | $25.0K | $24.8K | $22.0K | · | · | |
| Total Assets | $94M | $46M | $98M | $153M | $223M | $118M | $117M | $3M | $3M | · | · | |
| Accounts Payable | $2M | $4M | $4M | $5M | $11M | $8M | $522.7K | $765.4K | $529.6K | · | · | |
| Accrued Liabilities | $5M | $6M | $9M | $7M | $4M | $4M | $824.9K | $659.5K | $394.6K | · | · | |
| Short-term Debt | · | · | · | · | · | · | $110.2K | $285.2K | $276.7K | · | · | |
| Current Liabilities | $6M | $10M | $12M | $12M | $15M | $13M | $1M | $6M | $1M | · | · | |
| Total Liabilities | $7M | $10M | $12M | $12M | $15M | $13M | $1M | $9M | $1M | · | · | |
| Total Debt | · | · | · | · | · | · | · | $285.2K | · | · | · | |
| Common Stock | $73.3K | $30.2K | $30.1K | $30.1K | $27.7K | $16.3K | $14.5K | $12.6K | $12.5K | · | · | |
| Paid-in Capital | $785M | $676M | $646M | $603M | $513M | $285M | $236M | $89M | $87M | · | · | |
| Retained Earnings | $-698M | $-641M | $-561M | $-462M | $-305M | $-179M | $-120M | $-94M | $-85M | · | · | |
| Stockholders' Equity | $87M | $36M | $85M | $140M | $208M | $106M | $116M | $-6M | $1M | $7M | · | |
| Liabilities + Equity | $94M | $46M | $98M | $153M | $223M | $118M | $117M | $3M | $3M | · | · | |
| Shares Outstanding | 73,333,622 | 30,174,202 | 30,099,203 | 30,099,203 | 27,740,147 | 16,332,939 | 14,457,013 | 12,549,870 | 12,528,374 | · | · |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $30M | $44M | $44M | $40M | $21M | $3M | $518.0K | $704.5K | · | · | |
| Operating Cash Flow | $-46M | $-52M | $-52M | $-104M | $-92M | $-28M | $-12M | $-6M | $-6M | · | · | |
| CapEx | · | · | · | · | · | $182M | $85M | $12.4K | $49.7K | · | · | |
| Investing Cash Flow | $-48M | $52M | $50M | $20M | $-54M | $-34M | $-80M | $-12.4K | $-49.7K | · | · | |
| Stock Issued | $94M | · | · | $43M | $185M | $20M | · | · | · | · | · | |
| Net Stock Activity | $94M | · | · | $43M | $185M | $18M | · | · | · | · | · | |
| Financing Cash Flow | $94M | $-40.3K | $-98.5K | $45M | $188M | $28M | $126M | $7M | $-273.7K | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $528.4K | $-7M | · | · | |
| Free Cash Flow | · | · | · | · | · | $-210M | · | $-6M | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -2013.0% | -6063.3% | -10483.4% | -4348.0% | · | 517.5% | · | · | · | |
| Net Margin | · | · | -1917.7% | -5905.2% | -10487.4% | -4249.2% | · | 670.3% | · | · | · | |
| EBITDA Margin | · | · | -2013.0% | -6063.3% | -10483.4% | -4348.0% | · | 517.5% | · | · | · | |
| ROA | -82.1% | -111.6% | -78.9% | -83.5% | -73.6% | -50.5% | · | -304.5% | · | · | · | |
| ROE | -112.0% | -192.4% | -106.2% | -102.4% | -89.5% | -52.2% | · | 228.9% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 4.4 | 8.0 | 12.3 | 14.8 | 9.4 | · | 0.5 | · | · | · | |
| Quick Ratio | 14.5 | 4.4 | 7.9 | 11.9 | 11.1 | 9.3 | · | 0.4 | · | · | · | |
| Debt / Equity | · | · | · | · | · | · | · | -0.1 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | -0.5 | · | · | · | |
| Receivables Turnover | · | · | · | 10.4 | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.18 | $1.18 | $2.84 | $4.67 | $7.51 | $6.46 | · | $-0.44 | · | · | · | |
| Revenue / Share | · | · | $0.17 | $0.09 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-1.16 | $-1.72 | $-1.72 | $-3.50 | · | · | · | · | · | · | · | |
| Cash / Share | $0.05 | $0.13 | $0.14 | $0.18 | · | $0.15 | · | $0.18 | · | · | · | |
| EPS (TTM) | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 93.7% | 121.8% | -14.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 54.4% | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.5K | $5.5K | $5.5K | $5.5K | $5.5K | $5.5K | · | $5.5K | $5.5K | $5.5K | $5.5K | |
| Net Income TTM | $-57M | $-80M | $-99M | $-157M | $-126M | $-59M | · | $-9M | $-6M | · | · | |
| Market Cap | $354M | $16M | $125M | $105M | $625M | $524M | · | $51M | · | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | $49M | · | · | · | |
| P/E | -3.3 | -0.2 | -1.3 | -0.7 | -3.1 | · | · | · | · | · | · | |
| P/S | 64260.0 | 2846.6 | 22607.2 | 19057.7 | 113386.3 | 95028.5 | · | 9198.4 | · | · | · | |
| P/B | 4.1 | 0.4 | 1.5 | 0.7 | 3.0 | 5.0 | · | -9.2 | · | · | · | |
| P / Tangible Book | 4.1 | 0.4 | 1.5 | 0.7 | 3.0 | 5.0 | · | · | · | · | · | |
| P / Cash Flow | -7.7 | -0.3 | -2.4 | -1.0 | -6.8 | -18.8 | · | -8.4 | · | · | · | |
| P / FCF | · | · | · | · | · | -2.5 | · | -8.4 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | -7.0 | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | -8.1 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 8843.9 | · | · | · | |
| Earnings Yield | -30.0% | -509.6% | -79.2% | -151.9% | -31.8% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $8M | $8M | $8M | $4M | $3M | $12M | $11M | $11M | $11M | $13M | $15M | $10M | $14M | $16M | $27M | $31M | |
| SG&A Expense | $7M | $11M | $12M | $6M | $7M | $6M | $8M | $12M | $8M | $10M | $12M | $12M | $12M | $12M | $12M | $8M | |
| Operating Expenses | $15M | $19M | $20M | $10M | $10M | $18M | $19M | $23M | $19M | $23M | $27M | $23M | $26M | $28M | $39M | $39M | |
| Operating Income | $-15M | $-19M | $-20M | $-10M | $-10M | $-18M | $-19M | $-23M | $-19M | $-23M | $-27M | $-23M | $-26M | $-28M | $-39M | $-39M | |
| Interest Income | $2M | $959.8K | $387.2K | $247.0K | $321.5K | $440.3K | $654.6K | $856.5K | $963.0K | $1M | $1M | $1M | $1M | $1M | · | · | |
| Other Non-op | $2M | $409.8K | $465.4K | $235.8K | $354.9K | $659.0K | $418.4K | $1M | $1M | $1M | $2M | $690.6K | $723.8K | $2M | $758.1K | $-681.5K | |
| Net Income | $-13M | $-19M | $-20M | $-10M | $-10M | $-18M | $-19M | $-22M | $-18M | $-22M | $-25M | $-22M | $-25M | $-26M | $-38M | $-39M | |
| EPS (Basic) | $-0.11 | $-0.22 | $-0.27 | $-0.30 | $-0.30 | $-0.58 | $-0.62 | $-0.72 | $-0.59 | $-0.72 | $-0.84 | $-0.73 | $-0.84 | $-0.87 | $-1.26 | $-1.31 | |
| EPS (Diluted) | $-0.11 | $-0.22 | $-0.27 | $-0.30 | $-0.30 | $-0.58 | $-0.62 | $-0.72 | $-0.59 | $-0.72 | $-0.84 | $-0.73 | $-0.84 | $-0.87 | $-1.26 | $-1.31 | |
| Shares (Basic) | 112,375,941 | 86,596,873 | · | 33,191,622 | 33,191,622 | 30,408,890 | · | 30,174,202 | 30,174,202 | 30,132,170 | · | 30,099,203 | 30,099,203 | 30,099,203 | · | 30,063,735 | |
| Shares (Diluted) | 112,375,941 | 86,596,873 | · | 33,191,622 | 33,191,622 | 30,408,890 | · | 30,174,202 | 30,174,202 | 30,132,170 | · | 30,099,203 | 30,099,203 | 30,099,203 | · | 30,063,735 | |
| EBITDA | $-15M | $-19M | · | $-10M | $-10M | $-18M | · | $-23M | $-19M | $-23M | · | $-23M | $-26M | $-28M | · | $-39M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $10M | $3M | $1M | $1M | $1M | $4M | $1M | $2M | $1M | $4M | $7M | $14M | $29M | $5M | $43M | |
| Short-term Investments | $206M | $224M | $90M | $13M | $19M | $26M | $41M | $53M | $68M | $82M | $92M | $100M | $104M | $104M | $143M | $142M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $512.4K | · | |
| Prepaid Expense | $1M | $1M | $977.7K | $967.7K | $474.6K | $596.4K | $886.5K | $2M | $537.5K | $752.3K | $1M | $3M | $3M | $3M | $4M | $3M | |
| Current Assets | $219M | $235M | $94M | $15M | $21M | $28M | $46M | $56M | $71M | $84M | $98M | $109M | $122M | $136M | $153M | $187M | |
| Other Non-current Assets | $19.5K | $19.5K | $19.5K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $53.6K | $43.1K | $43.1K | $47.7K | $34.6K | $34.9K | $34.9K | $16.1K | |
| Total Assets | $219M | $235M | $94M | $15M | $21M | $28M | $46M | $56M | $71M | $84M | $98M | $109M | $122M | $136M | $153M | $187M | |
| Accounts Payable | $2M | $6M | $2M | $1M | $1M | $1M | $4M | $2M | $4M | $5M | $4M | $3M | $5M | $4M | $5M | $10M | |
| Accrued Liabilities | $5M | $7M | $5M | $4M | $4M | $4M | $6M | $6M | $5M | $7M | $9M | $6M | $6M | $6M | $7M | $10M | |
| Current Liabilities | $7M | $13M | $6M | $5M | $5M | $5M | $10M | $8M | $10M | $12M | $12M | $8M | $11M | $10M | $12M | $21M | |
| Total Liabilities | $13M | $17M | $7M | $5M | $5M | $5M | $10M | $8M | · | $12M | $12M | · | · | $10M | $12M | · | |
| Common Stock | $106.7K | $104.9K | $73.3K | $33.2K | $33.2K | $33.2K | $30.2K | $30.2K | $30.2K | $30.2K | $30.1K | $30.1K | $30.1K | $30.1K | $30.1K | $28.6K | |
| Paid-in Capital | $937M | $936M | $785M | $688M | $684M | $681M | $676M | $670M | $662M | $655M | $646M | $636M | $625M | $614M | $603M | $590M | |
| Retained Earnings | $-730M | $-717M | $-698M | $-678M | $-668M | $-658M | $-641M | $-622M | $-600M | $-583M | $-561M | $-536M | $-514M | $-488M | $-462M | $-424M | |
| Stockholders' Equity | $207M | $219M | $87M | $9M | $16M | $22M | $36M | $48M | $61M | $72M | $85M | $101M | $111M | $125M | $140M | $166M | |
| Liabilities + Equity | $219M | $235M | $94M | $15M | $21M | $28M | $46M | $56M | $71M | $84M | $98M | $109M | $122M | $136M | $153M | $187M | |
| Shares Outstanding | 106,669,846 | 104,890,223 | 73,333,622 | 33,191,622 | 33,191,622 | 33,191,622 | 30,174,202 | 30,174,202 | 30,174,202 | 30,174,202 | 30,099,203 | 30,099,203 | 30,099,203 | 30,099,203 | 30,099,203 | 28,641,991 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $902.9K | $956.2K | $2M | $4M | $3M | $4M | $7M | $8M | $7M | $8M | $10M | $11M | $11M | $11M | $12M | $8M | |
| Operating Cash Flow | $-10M | $-15M | $-15M | $-7M | $-6M | $-18M | $-9M | $-17M | $-13M | $-13M | $-10M | $-12M | $-13M | $-17M | $-36M | $-27M | |
| Investing Cash Flow | $18M | $-135M | $-77M | $7M | $7M | $15M | $11M | $16M | $14M | $10M | $8M | $4M | $-1M | $40M | $-2M | $32M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Stock Repurchased | $6M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-6M | $157M | $94M | $0 | · | · | $-172.5K | $-89.6K | $0 | $221.7K | · | · | · | · | $409.9K | $569.1K | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $-14M | $23M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -1717.3% | -1909.0% | -2331.3% | · | -4680.6% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -1665.0% | -1855.9% | -2179.6% | · | -4762.9% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -1717.3% | -1909.0% | -2331.3% | · | -4680.6% | |
| ROA | -10.8% | -14.5% | · | -28.6% | -21.4% | -31.3% | · | -26.4% | -18.4% | -19.9% | · | -14.8% | -15.0% | -14.6% | · | -28.3% | |
| ROE | -11.6% | -15.8% | · | -35.4% | -25.5% | -37.2% | · | -29.3% | -20.6% | -22.1% | · | -16.5% | -16.4% | -15.7% | · | -33.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 29.5 | 18.3 | · | 2.9 | 4.1 | 5.3 | · | 6.9 | 7.4 | 6.8 | · | 13.0 | 11.4 | 13.4 | · | 9.0 | |
| Quick Ratio | 29.3 | 18.1 | · | 2.7 | 4.0 | 5.2 | · | 6.7 | 7.4 | 6.8 | · | 12.6 | 11.1 | 13.1 | · | 8.9 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.94 | $2.09 | · | $0.29 | $0.48 | $0.68 | · | $1.58 | $2.04 | $2.39 | · | $3.35 | $3.70 | $4.17 | · | $5.81 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | $0.04 | $0.05 | $0.04 | · | $0.03 | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.59 | · | · | · | $-0.43 | · | · | · | $-0.55 | · | · | |
| Cash / Share | $0.11 | $0.09 | · | $0.04 | $0.04 | $0.03 | · | $0.05 | $0.07 | $0.04 | · | $0.22 | $0.48 | $0.96 | · | $1.48 | |
| EPS (TTM) | $-0.90 | $-1.09 | · | $-1.80 | $-2.22 | $-2.51 | · | $-2.87 | $-2.88 | $-3.13 | · | $-3.70 | $-4.28 | $-4.77 | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.2K | $3.2K | · | $3.2K | $3.2K | $3.2K | · | $3.2K | $3.2K | $3.2K | · | $3.2K | $3.2K | $3.2K | · | $3.2K | |
| Net Income TTM | $-62M | $-59M | · | $-56M | $-68M | $-76M | · | $-86M | $-87M | $-94M | · | $-112M | $-129M | $-144M | · | $-153M | |
| Market Cap | $738M | $730M | · | $67M | $20M | $9M | · | $98M | $91M | $140M | · | $90M | $74M | $68M | · | $1.06B | |
| P/E | -7.7 | -6.4 | · | -1.1 | -0.3 | -0.1 | · | -1.1 | -1.0 | -1.5 | · | -0.8 | -0.6 | -0.5 | · | · | |
| P/S | 233150.8 | 230586.2 | · | 21072.4 | 6290.3 | 2830.6 | · | 30879.5 | 28592.1 | 44317.8 | · | 28521.0 | 23387.3 | 21485.8 | · | 334910.5 | |
| P/B | 3.6 | 3.3 | · | 7.0 | 1.2 | 0.4 | · | 2.1 | 1.5 | 1.9 | · | 0.9 | 0.7 | 0.5 | · | 6.4 | |
| P / Tangible Book | 3.6 | 3.3 | · | 7.0 | 1.2 | 0.4 | · | 2.1 | 1.5 | 1.9 | · | 0.9 | 0.7 | 0.5 | · | 6.4 | |
| P / Cash Flow | · | -48.5 | · | · | · | -0.5 | · | · | · | -10.8 | · | · | · | -4.1 | · | · | |
| Earnings Yield | -13.0% | -15.7% | · | -89.5% | -370.0% | -929.6% | · | -88.6% | -96.0% | -67.3% | · | -123.3% | -174.0% | -211.1% | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı % | · | · | -2013.0% | -6063.3% | -10483.4% |
| Net Gelir | $-57M | $-80M | $-99M | $-157M | $-126M |
| Seyreltilmiş Hisse Başı Kâr | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 14.6 | 4.4 | 8.0 | 12.3 | 14.8 |
| Cari Oran | 14.5 | 4.4 | 7.9 | 11.9 | 11.1 |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 131 dosya · $695.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
131
Tutulan Değer
$695.4M
Yeni pozisyonlar
48
Çıkan pozisyonlar
23
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 48 (+11 önceki Ç'ye göre) | 23 (+15 önceki Ç'ye göre) | 35 (+7 önceki Ç'ye göre) | 23 (-2 önceki Ç'ye göre) | +5.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $76.892.206 | 11.063.862 | 11,06% | Hisse senetleri |
| BlackRock, Inc. | $51.393.319 | 7.426.780 | 7,39% | Hisse senetleri |
| Squadron Capital Management LLC | $50.862.000 | 7.350.000 | 7,31% | Hisse senetleri |
| Venrock Adviser, LLC | $47.362.591 | 6.844.305 | 6,81% | Hisse senetleri |
| Spruce Street Capital LP | $44.227.990 | 6.391.328 | 6,36% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $32.961.053 | 4.763.158 | 4,74% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.864.653 | 4.460.210 | 4,44% | Hisse senetleri |
| Jones Hill Capital LP | $25.293.119 | 3.655.075 | 3,64% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $25.127.869 | 3.631.195 | 3,61% | Hisse senetleri |
| STATE STREET CORP | $17.421.446 | 2.517.550 | 2,51% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $17.253.429 | 2.492.573 | 2,48% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $16.343.843 | 2.361.827 | 2,35% | Hisse senetleri |
| MARSHALL WACE, LLP | $15.548.126 | 2.246.839 | 2,24% | Hisse senetleri |
| Ikarian Capital, LLC | $14.866.644 | 2.148.359 | 2,14% | Hisse senetleri |
| Driehaus Capital Management LLC | $14.753.807 | 2.132.053 | 2,12% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $13.410.767 | 1.937.972 | 1,93% | Hisse senetleri |
| EVENTIDE ASSET MANAGEMENT, LLC | $12.860.239 | 1.858.416 | 1,85% | Hisse senetleri |
| Balyasny Asset Management L.P. | $10.523.161 | 1.520.688 | 1,51% | Hisse senetleri |
| STEMPOINT CAPITAL LP | $10.103.844 | 1.460.093 | 1,45% | Hisse senetleri |
| Commodore Capital LP | $9.861.000 | 1.425.000 | 1,42% | Hisse senetleri |
| Polar Capital Holdings Plc | $9.275.762 | 1.340.428 | 1,33% | Hisse senetleri |
| CITADEL ADVISORS LLC | $7.346.722 | 1.061.665 | 1,06% | Hisse senetleri |
| Sio Capital Management, LLC | $6.944.649 | 1.003.562 | 1,00% | Hisse senetleri |
| Opaleye Management Inc. | $6.470.200 | 935.000 | 0,93% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.215.530 | 898.198 | 0,89% | Hisse senetleri |
| Boxer Capital Management, LLC | $5.827.374 | 842.106 | 0,84% | Hisse senetleri |
| Soleus Capital Management, L.P. | $5.827.374 | 842.106 | 0,84% | Hisse senetleri |
| GREAT POINT PARTNERS LLC | $5.827.374 | 842.106 | 0,84% | Hisse senetleri |
| VANGUARD GROUP INC | $5.811.973 | 1.203.307 | 0,84% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $5.619.449 | 812.059 | 0,81% | Hisse senetleri |
| NORTHERN TRUST CORP | $5.440.898 | 786.257 | 0,78% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $5.311.958 | 767.624 | 0,76% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $5.080.602 | 734.191 | 0,73% | Hisse senetleri |
| Qube Research & Technologies Ltd | $4.785.491 | 691.545 | 0,69% | Hisse senetleri |
| Walleye Capital LLC | $4.264.367 | 616.238 | 0,61% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $3.908.132 | 564.759 | 0,56% | Hisse senetleri |
| Integral Health Asset Management, LLC | $3.460.000 | 500.000 | 0,50% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $3.127.273 | 451.918 | 0,45% | Hisse senetleri |
| Knott David M Jr | $3.120.920 | 451.000 | 0,45% | Hisse senetleri |
| HighVista Strategies LLC | $3.084.929 | 445.799 | 0,44% | Hisse senetleri |
| AdvisorShares Investments LLC | $3.037.195 | 438.901 | 0,44% | Hisse senetleri |
| Birchview Capital, LP | $2.824.052 | 408.100 | 0,41% | Hisse senetleri |
| DIADEMA PARTNERS LP | $2.500.660 | 361.367 | 0,36% | Hisse senetleri |
| PARSONS CAPITAL MANAGEMENT INC/RI | $2.450.158 | 354.069 | 0,35% | Hisse senetleri |
| Seven Fleet Capital Management LP | $2.409.994 | 348.265 | 0,35% | Hisse senetleri |
| Harvest Investment Services, LLC | $2.358.959 | 340.890 | 0,34% | Hisse senetleri |
| Woodline Partners LP | $2.272.673 | 328.421 | 0,33% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $2.206.802 | 318.902 | 0,32% | Hisse senetleri |
| SEVEN GRAND MANAGERS, LLC | $2.185.253 | 315.788 | 0,31% | Hisse senetleri |
| Bank of New York Mellon Corp | $2.045.711 | 295.623 | 0,29% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Laidlaw & Company (UK) Ltd., Matthew D. Eitner, James P. Ahern, Dr. John H. Leaman, Dr. Todd Johnson, Benjamin H. Snedeker, David Buchen, Timothy S. Callahan ×8 başvurular | 02 Haziran 2016 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 14 içeriden öğrenenler · 8 yöneticiler · 8 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Sergio Traversa | Chief Executive Officer | 10 Eylül 2026 P | 1.500.000 | 4 | 0 | $1.540.800 |
| Maged Shenouda | Chief Financial Officer | 10 Eylül 2026 P | 1.000.000 | 4 | 0 | $1.992.050 |
| Douglas Beck | Chief Financial Officer | 23 Şubat 2015 A | · | 0 | 0 | $0 |
| Eliseo Oreste Salinas | President and CSO | 23 Şubat 2015 A | · | 0 | 0 | $0 |
| Paul Edward Kelly | COO | 12 Aralık 2025 A | 502.295 | 1 | 0 | $198.000 |
| Chuck Ence | CA and CO | 12 Aralık 2025 A | 403.931 | 1 | 0 | $299.200 |
| Cedric O'Gorman | Chief Medical Officer | 23 Mayıs 2023 P | 10.121 | 0 | 0 | $0 |
| Ottavio V. Vitolo | CMO | 19 Aralık 2019 A | · | 0 | 0 | $0 |
| Fabiana Fedeli | Yönetim kurulu üyesi | 12 Aralık 2025 A | · | 0 | 0 | $0 |
| John Glasspool | Yönetim kurulu üyesi | 12 Aralık 2025 A | · | 0 | 0 | $0 |
| Charles J Casamento | Yönetim kurulu üyesi | 12 Aralık 2025 A | 0 | 0 | 0 | $0 |
| Eric Thomas Schmidt | Yönetim kurulu üyesi | 25 Mayıs 2023 A | 100.000 | 0 | 0 | $0 |
| Shreeram Agharkar | Yönetim kurulu üyesi | 31 Aralık 2015 P | 5.759 | 0 | 0 | $0 |
| Sandesh Seth | Yönetim kurulu üyesi | 15 Aralık 2015 P | 123.258 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 16 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,61% | 23.536 NS | 31 Temmuz 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,54% | 46.738 NS | 31 Temmuz 2026 | N-PORT |
| IBRN · iShares Trust | 0,39% | 7.221 SH | 11 Eylül 2026 | Günlük |
| IWC · iShares Trust | 0,09% | 322.021 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 101.233 SH | 19 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,03% | 898.892 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 544.580 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,02% | 45.005 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 2.390.544 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.204.524 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 244.563 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 68.632 SH | 01 Ekim 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 164.954 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 30.310 SH | 09 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.169.804 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.822 SH | 19 Ağustos 2026 | Günlük |
RLMD Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 11 analist
AL
Medyan hedef
$11.00
+205,6%
4 36,4%
Güçlü Al
6 54,5%
Al
1 9,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
4 analist · 2026-09-29Ortalama hedef $10.75 +198,6%
← Tüm hedeflerin altında
Mevcut fiyat $3.60
Düşük$9.00
Ortalama$10.75
Yüksek$12.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| RLMD | $354M | -3.3 | 93.7% | · | -112.0% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| AVIR | $279M | -1.8 | · | · | -49.5% | · |
| TTRX | $116M | -32.8 | · | · | -141.7% | · |
| BIOA | $495M | -5.9 | · | -896.1% | -28.4% | · |
| FULC | $753M | -9.6 | 2752.0% | · | -26.6% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026